This signaling was also linked to BRCA1-associated breast cancer risk with the identification of cGAS-stimulator of interferon genes (STING) and innate immune system-related gene sets in the analysis of the GWAS results (Supplementary Data 1a). This evidence concerns the gene BRCA1 and breast carcinoma.